International Finance Facility for Immunisation: building a financial lifeline from the world’s investors to its poorest children
Every year, 19 million children miss out on vaccines against common diseases. 1.7 million die from easily-preventable diseases
Shortage of secure, predictable funding stops developing countries planning long-term health programmes for their children
IFFIm was set-up in 2006 to accelerate the availability and predictability of funds for immunisation programmes
IFFIm raises finance by issuing 'vaccine bonds' in capital markets, converting long-term government pledges into immediate cash
UK, France, Italy, Norway, Australia, Spain, the Netherlands, Sweden, South Africa have committed US$ 6.3 billion to IFFIm over 23 years
IFFIm funds help the Global Alliance for Vaccines and Immunisation. In 12 years, GAVI has prevented over 5.5 million future deaths
IFFIm funds catalyse uptake of vaccines against diphtheria, tetanus, pertussis, hepatitis B, Haemophilus influenzae type b
IFFIm funds strengthen immunisation and health service delivery through health worker training and support for cold chain and logistics
IFFIm supports polio and yellow fever vaccines, measles mortality reduction, maternal & neonatal tetanus
Thanks to IFFIm, GAVI has been able to nearly double its support for vaccine introduction in developing countries since 2006
Welcome to the new IFFIm website with easier to find content, case studies of IFFIm’s real-life impact on immunisation and an improved library section.
17 January 2012Standard & Poor’s research update
21 December 2011
Moody’s Investors Service credit analysis
19 December 2011
Fitch Ratings press release
Dr. Karsenti brings to IFFIm a background both in the capital markets and development finance.
Français 日本語
IFFIm press releases
Learn more about IFFIm
Learn how IFFIm has played a critical role in polio eradication with a US$ 191 million investment.
US$ 1.2 billion for GAVI-eligible countries has increased global uptake of new & underused vaccines.
More videos...
Download presentation on IFFIm
IFFIm: the challenge, the solution, the results
Read the June 2011 IFFIm Evaluation documents
The GAVI Alliance was set-up in 2000 to save children's lives and protect people's health by increasing access to immunisation in developing countries.
US$ 1.8 billion of disbursements have doubled expenditures for the GAVI Alliance on health.
To date, nine donors have pledged US$ 6.3 billion to IFFIm over 23 years.
03 February 2012
René Karsenti to become new Chair of IFFIm Board
Outgoing Chair Alan Gillespie oversaw raising of US$ 3.6 billion. [Français] [日本語]
17 January 2012
IFFIm rating action by Standard & Poor’s follows sovereign donor downgrades
Standard & Poor’s (S&P) has downgraded the International Finance Facility for Immunisation Company (IFFIm) by one notch from AAA to AA+.
Download IFFIm Update no.6
11 January 2012
Advancing the Global Health Agenda
UN Chronicle
09 December 2011
The art of making vaccines more affordable - Seth Berkley
Global Health Magazine
05 December 2011
The Intersection of Innovative Financing and Global Health
Devex
Japan International Cooperation Agency to issue bonds to investors
JICA
17 November 2011
Green light from GAVI for cervical cancer vaccine
The Guardian
02 October 2011
Making money in pursuit of social good
Financial Times
27 September 2011
Gates-Backed Alliance To Prevent Pneumonia, Diarrhea In Children
Forbes
20 September 2011
Poor Countries Lead in Mother, Child Spending
The New York Times
25 August 2011
Impact investing: Harbinger of A Brighter Future and A Friendlier Bond Market?
Forbes India Magazine
14 August 2011
Seth Berkley: A lifetime search for equity through vaccines
The East African
modal window here